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Abstract We applied a high-throughput strategy for the
screening of targets for structural proteomics of Xanthomonas
axonopodis pv citri. This strategy is based on the rapid 1H^15N
HSQC NMR analysis of bacterial lysates containing selectively
15N-labelled heterologous proteins. Our analysis permitted us to
classify the 19 soluble candidates in terms of ‘foldedness’, that
is, the extent to which they present a well-folded solution struc-
ture, as re£ected by the quality of their NMR spectra. This
classi¢cation allowed us to de¢ne a priority list to be used as
a guide to select protein candidates for further structural stud-
ies.
. 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Structural proteomics is a rapidly developing ¢eld in biol-
ogy [1^4]. It involves the determination of protein structures
on a genome-wide scale and is expected to yield invaluable
information about protein folding and protein function. Sev-
eral recent examples have demonstrated the feasibility of ob-
taining functional information through structure [5^7].
Structural proteomics requires a large-scale approach to
structural biology and, although rapidly evolving, still
presents important bottlenecks that need to be overcome
[8,9]. Methods have been developed for high-throughput clon-
ing, expression and puri¢cation of target open reading frames
(ORFs) [9^12]. Important developments have also been made
in automated procedures for X-ray crystallography [12^14]
and nuclear magnetic resonance (NMR) spectroscopy struc-
ture determination [15^19]. However, important issues, such
as the acquisition of well-di¡racting crystals and size limita-
tion in NMR, decrease the speed and e⁄ciency of the process.
Furthermore, the study of uncharacterized proteins inevitably
begins with a large number of candidates that are progres-
sively eliminated due to problems related to expression levels,
solubility and stability.
A major challenge of structural proteomics is to select the
target proteins in a realistic, e⁄cient and cost-e¡ective way. In
order to optimize this process, it would be desirable to have a
rapid and e⁄cient method for screening target ORFs for their
suitability for structural studies. Several methods have been
developed to screen candidates for structural studies, such as
cell free expression systems [20,21] and enzymatic labeling of
glutamine in vitro [22] and selective isotopic labeling of the
target proteins in vivo [23].
In this paper we describe the use of a high-throughput
strategy for screening structural proteomics targets by apply-
ing it to a set of 35 previously uncharacterized ORFs of the
recently sequenced Xanthomonas axonopodis pv citri (X. a. pv
citri) phytopathogen [24]. This strategy is based on the NMR
analysis of bacterial lysates containing selectively 15N-labelled
heterologous proteins as originally described by Almeida et al.
[23]. By omitting the puri¢cation step, this protocol is a fast,
e⁄cient and inexpensive method to select proteins with con-
formational characteristics amenable to further structural
analysis by NMR and/or X-ray crystallography.
2. Materials and methods
2.1. Cloning and expression
Targets were ampli¢ed by PCR from X. a. pv citri genomic DNA
[24], subcloned into the pET-3a vector and expressed in Escherichia
coli strain BL21(DE3)pLysS [25]. Cells were grown at 37‡C in unla-
belled M9 medium up to an OD600 nm of 0.8 and heterologous protein
expression induced by 1 mM isopropyl-L-D-thiogalactoside (IPTG).
After 15 min, rifampicin was added to a concentration of 200 Wg
ml31. Upon 15 min of further incubation, the cells were pelleted
and resuspended in M9 medium containing 1 g l31 15NH4Cl, 1 mM
IPTG and 200 Wg ml31 rifampicin. Cells were grown for 3.5 h before
harvesting and storage at 370‡C.
2.2. NMR screening
Frozen cell pellets were thawed by adding 500 Wl of 20 mM sodium
phosphate (pH 7.0), 10 mM L-mercaptoethanol, 40 Wg ml31 PMSF
and lysed by sonication. Lysates were clari¢ed by centrifugation and
the soluble fraction was concentrated using a 3 kDa cuto¡ Centricon
¢lter. 10% D2O was added to the sample. Standard 1D 1H spectra,
1D 15N-edited 1H spectra and 2D 1H^15N heteronuclear single quan-
tum coherence (HSQC) spectra were collected at 303 K in a Bruker
Advance DRX 600 MHz. XACb0070 HSQC data were also acquired
on a Varian INOVA 600 MHz instrument at the Laborato¤rio Nacio-
nal de Luz Sincrotron in Campinas, Brazil. All NMR experiments
took an average of 8 h for each sample.
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3. Results and discussion
3.1. Selection of target ORFs
Thirty-¢ve X. a. pv citri gene products [24] were selected on
the basis of size (79^330 amino acids), predicted cytosolic
localization using PSORT [27], methionine content
(s 1.1%), low sequence relatedness to proteins of known
function and the presence of homologs in the genomes of
other organisms (so-called ‘conserved hypothetical proteins’)
[27]. Targets were also selected for absence of homologs in the
Fig. 1. 1D 15N-edited1H HSQC spectra of the 19 soluble proteins obtained from soluble cell lysates after selective 15N-labelling. Spectra are
grouped as good (a), promising (b) and poor (c). Classi¢cation is based on the analysis of chemical shift dispersion and line-width. The number
above the spectra identi¢es the ORF encoding the expressed protein with the number of amino acid residues shown in parentheses.
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PDB (Protein Data Bank, identi¢ed using PSI-BLAST [28]
according to the method of Huynen et al. [29].
3.2. Expression and solubility
The 35 selected ORFs were ampli¢ed and expressed as de-
scribed in Section 2 [25]. Expression levels and solubility were
monitored using SDS^PAGE (sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis) by the intensity of the induced
band present in the cell lysate, pellet and supernatant. Most
proteins (31/35) expressed well in E. coli grown in M9 mini-
mum medium, and 19 of the expressed proteins remained in
the soluble fraction of the cell lysates.
Fig. 2. 2D 15N-edited 1H HSQC spectra of the 19 soluble proteins obtained from soluble cell lysates after selective 15N-labelling. Spectra are
grouped as good (a), promising (b) and poor (c). Classi¢cation is based on the analysis of chemical shift dispersion, line-width and number of
peaks. Spectra are presented in the same order as shown in Fig. 1. The number above the spectra identi¢es the ORF encoding the expressed
protein with the number of amino acid residues shown in parentheses.
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3.3. Selective 15N-labeling
The 19 soluble proteins were selectively labelled with 15N as
described by Almeida et al. [23]. This methodology uses the
antibiotic rifampicin to selectively label heterologous proteins
for NMR studies. By ‘selective’ we mean to indicate that only
the heterologously expressed protein was labeled with 15N.
Rifampicin is a bacterial RNA polymerase inhibitor that
does not inhibit T7 polymerase used for expression of heter-
ologous proteins cloned under the control of T7 promoters, as
in the case of pET vectors [25]. Thus, heterologous protein
expression induction following transfer of the bacteria into
isotopically labelled minimal medium supplemented with ri-
fampicin enables the selective labelling of heterologous pro-
teins with an isotope of choice.
3.4. Screening by 1H^ 15N HSQC
The soluble fractions of the 19 cell lysates containing the
selectively 15N-labelled heterologous proteins were rapidly
screened by 1D (Fig. 1) and 2D 1H^15N HSQC (Fig. 2). It
has long been recognized that chemical shift contains struc-
tural information [30,31]. Furthermore, NMR spectra of well-
folded proteins exhibit sharp lines and large chemical shift
dispersion, while unfolded proteins present spectra with small
chemical shift dispersion and often contain broad lines, due to
conformational exchange. Thus, the combined analysis of
chemical shift dispersion and line-width provides information
about the conformational state of the protein in solution, or
its ‘foldedness’, which could be used as criteria for selecting
good protein candidates for further structural analysis
[31,32,33].
Fig. 1 shows the 1D HSQC spectra obtained for all 19 X. a.
pv citri protein targets screened in this study. According to the
quality of the spectra proteins could be empirically grouped.
The spectra obtained were classi¢ed as good when showing
sharp, intense and well-dispersed peaks characteristic of
well-structured, stable proteins (Fig. 1a). Spectra showing
broader, less intense and less dispersed peaks than expected
for a stable and well-structured protein were classi¢ed as
promising (Fig. 1b). Such spectra often indicate conformation
heterogeneity or dynamic processes on a slow time scale that
Fig. 3. 1H spectra (a,b,c), 15N-edited 1H spectra (d,e,f) and 2D 15N-edited 1H HSQC spectra (g,h,i) for the proteins encoded by ORFs
XAC2775 and XAC0862: soluble bacterial lysates containing 15N-labelled proteins encoded by ORF XAC2775 (a,d,g) and ORF XAC0862
(b,e,h); puri¢ed XAC0862protein product (c,f,i).
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can broaden the NMR signal. Poor spectra were characterized
by a cluster of broad peaks with low chemical shift dispersion
(Fig. 1c). These spectra are likely to represent unfolded, con-
formationally unstable or aggregated proteins.
The 2D HSQC NMR spectra for all 19 soluble proteins are
presented in Fig. 2 and again ordered according to the quality
of the spectra. The conclusions derived from the 2D HSQC
spectra are consistent with those from the 1D HSQC experi-
ments. In addition, in the 2D spectra one can compare the
observed number of peaks to that expected according to the
primary sequence. As the 2D HSQC spectra are more infor-
mative than the 1D spectra, the ¢nal priority list as shown in
Figs. 1 and 2 was built based mostly on the 2D spectra.
Fig. 3 compares the 1H spectra and the HSQC spectra of
the cell lysates after expression of two proteins: XAC2775
(Fig. 3a,d,g) and XAC0862 (Fig. 3b,e,h), which presented
poor and good spectra, respectively. Fig. 3 also shows the
spectra of the puri¢ed XAC0862 protein (Fig. 3c,f,i). The
1H spectra of the two lysate samples (Fig. 3a,b) are very
similar as resonances from all the soluble components in the
cell lysate appear. In contrast, the HSQC spectra present few-
er and more de¢ned peaks that correspond to the amide pro-
tons of the 15N-labelled heterologous proteins (Fig. 3d,e,g,h).
Note that the 1D 15N-edited 1H HSQC spectra (Fig. 3d,e) are
clearly di¡erent from each other, re£ecting distinct structural
characteristics. The spectrum for protein XAC2775 (Fig. 3d)
shows low dispersion, HN peaks falling between 7.5 and 8.5
ppm. On the other hand, the spectrum for protein XAC0862
(Fig. 3e) shows a wide dispersion of amide proton peaks (6.5^
9.5 ppm), indicative of a well-folded protein. The 2D HSQC
spectra (Fig. 3g,h) of the soluble bacterial lysates con¢rm
these observations, but in more detail. Speci¢cally, the spec-
trum for protein XAC2775 contains a small number of broad
lines (Fig. 3g) while that of protein XAC0862 contains a large
number of sharp well-resolved lines (Fig. 3h). Additionally,
the number of peaks observed in the XAC0862 2D spectrum
match with that expected from the primary sequence (143).
Comparison of the spectra of the XAC0862 bacterial lysate
(Fig. 3b,e,h) with the puri¢ed protein (Fig. 3c,f,i) con¢rms
that rifampicin allows the selective labelling of the heterolo-
gous protein alone as previously shown [23], and that the
lysate spectra of the 15N-labelled protein provides valuable
information about protein conformation.
Besides XAC0862, three other good candidates were puri-
¢ed to homogeneity after labeling with 15N. The HSQC spec-
tra of these puri¢ed proteins are presented in Fig. 4. The
spectra for puri¢ed XAC2000, XAC2396 and XAC3873
(Fig. 4) are very similar to those observed for their corre-
sponding bacterial lysates. For XAC2000 and XAC2396, the
observed number of peaks in the 2D spectra are in good
Fig. 4. 2D 15N-edited 1H HSQC spectra of puri¢ed proteins from ORFs XAC2000, XAC2396, XAC3873 and XACb0070. Spectra were ac-
quired at 25‡C and pH 7.0.
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agreement with the expected number of peaks. These results
are consistent with the hypothesis that most of the proteins
presenting good spectra may in fact be well-folded proteins
even in the bacterial lysates and that they maintain their
folded state during the puri¢cation procedure. The 2D
HSQC spectra of the unpuri¢ed and puri¢ed fractions of
XAC3873 are also very similar and show good peak disper-
sion. However, in this case only 102 of the 164 expected peaks
were observed in both. This may indicate overlap of resonan-
ces due to high helical content or to a well-folded domain
consisting of a little more than half of the polypeptide chain.
In the case of ambiguity, well-folded proteins may also be
distinguished using pulse sequences that enable the identi¢ca-
tion of non-hydrogen bonded amide protons present in less
structured regions of the protein and in fast exchange with
water [26,36,37].
3.5. Prioritizing protein targets for further structural studies
The purpose of the screening protocol is to create a priority
list to be used as a guide for choosing suitable protein candi-
dates for the more expensive and time-consuming puri¢cation
and structure determination phases of a medium- or large-
scale structural biology project. The method described here
allowed us to assess the conformational state of the protein
in solution without the need of previous puri¢cation.
The spectra evaluated as ‘promising’ in Figs. 1 and 2 gen-
erally presented a lower degree of chemical shift dispersion
than the good spectra but sharper and more intense lines
than the poor spectra. In some cases, a narrow range of 1H
chemical shifts may be indicative of high K-helical content and
not necessarily random coil conformations. One promising
candidate, protein XACb0070, that showed sharp peaks but
a low degree of 1H chemical shift dispersion, was puri¢ed in a
soluble and stable form. The 2D HSQC spectrum of the pu-
ri¢ed protein (Fig. 4) is similar to that observed in the bacte-
rial lysate (Fig. 2b), although not the same. The number of
amide peaks observed is close to that expected from its pri-
mary sequence (93). This protein aggregates at concentrations
greater than 500 WM, which may contribute, in part, to the
observed di¡erences. Furthermore, there are many examples
in the literature of large-scale 1H and 15N chemical shift
changes induced by the binding of inorganic and organic co-
factors [33^35]. Such factors would be present in the bacterial
lysate but probably absent in the puri¢ed protein. The CD
spectrum of the puri¢ed spectrum obtained was typical for an
K-helical protein (data not shown).
It must be noted that during the screening procedure no
protein-speci¢c optimization whatsoever was carried out for
the expression or lysis, prior to NMR analysis. Therefore
proteins low in the priority list should not be discarded.
Folded proteins that interact with cellular components would
hamper the HSQC quality. In principle, it would be di⁄cult
to distinguish between natively unfolded proteins and mis-
folded proteins using our methodology [38].
Selective 15N-labelling using rifampicin for NMR screening
was originally described and tested using proteins whose
structure and stability were previously known [23]. It was
not known whether this methodology would be e¡ective
when analyzing unknown structural proteomics targets. To
determine the e⁄ciency of this method for screening targets
for structural proteomics, we screened 35 previously unchar-
acterized X. a. pv citri proteins. In total, 42% of the tested
proteins showed good NMR spectra, 32% showed promising
spectra and 26% showed poor spectra (Fig. 5a). One of the
concerns of using HSQC spectra to screen for well-folded
proteins was that, given the size limitation of NMR, the
best spectra would correspond to the smaller proteins tested
whereas poor spectra would be observed for larger proteins.
We nevertheless found examples of small and large proteins
producing all types of spectra (good, promising and poor) (Fig.
5b). This shows that this method is suitable for creating a
priority list for structural proteomics candidates, regardless
of their size, provided they are su⁄ciently small for NMR
analysis. ‘Foldedness’ de¢ned in this way may also be of value
in the screening stages of large-scale protein crystallization
projects[31,32].
There are several published methods to screen promising
candidates for structural proteomics projects [12,31,32,33,
39]. Yee et al. [33] recently described the screening of 513
structural proteomics candidates from several genomes using
e⁄cient large-scale a⁄nity puri¢cation of His-tagged 15N-la-
belled proteins followed by HSQC analysis. The combination
of selective 15N-labelling of heterologous proteins with the
rapid analysis of soluble cell lysates by NMR spectroscopy
described here provides a promising alternative method for
rapidly and e⁄ciently screening structural proteomics targets
for future high-resolution studies by NMR or X-ray crystal-
lography.
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